Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

The Effectiveness of Combined Pelvic Floor Muscle Training and Vaginal Oestrogen Therapy in Postmenopausal Women With Stress Urinary Incontinence

Study ID: NCT07186985
Start Date: 2025-11-01
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

115

Intervention / Treatment

Combined Pelvic Floor Muscle Training and Vaginal Oestrogen Therapy

Vaginal estrogen

Sponsor

Hanoi Medical University

Source: clinicaltrials.gov

Share:
Add to list

Functional Substrate-Only Guided VT Ablation

Study ID: NCT06464315
Start Date: 2025-10-01
End Date: 2030-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Functional Substrate-Only Mapping without VT Induction

Standard-of-Care Mapping/Imaging

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window

Study ID: NCT06987305
Start Date: 2025-10-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

820

Intervention / Treatment

Intravenous rhTNK-tPA

Intravenous placebo

Endovascular thrombectomy

Sponsor

Xinqiao Hospital of Chongqing

Source: clinicaltrials.gov

Share:
Add to list

Echo-guided Scalp Blocks and Incidence of Postoperative Pain in Scheduled Supratentorial Intracranial Surgery.

Study ID: NCT07149077
Start Date: 2026-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

230

Intervention / Treatment

Echo-guided scalp blocks

Classic anesthetic strategy

Sponsor

University Hospital, Bordeaux

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Study ID: NCT07140900
Start Date: 2025-10-07
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

Hemuriteramy

Darolutami

Abiraterone

Sponsor

Amgen

Source: clinicaltrials.gov

Share:
Add to list

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Study ID: NCT05909137
Start Date: 2026-02
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

IMRT+adjuvant immunotherapy

Sponsor

Xinqiao Hospital of Chongqing

Source: clinicaltrials.gov

Share:
Add to list

Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients

Study ID: NCT06845319
Start Date: 2025-11-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

43

Intervention / Treatment

Carboplatin

Paclitaxel

Pembrolizumab

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations

Study ID: NCT06264531
Start Date: 2025-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

54

Intervention / Treatment

Infatuating

Placebo

Sponsor

Rothschild Adolphe Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Pediatric eCART Implementation

Study ID: NCT06771830
Start Date: 2025-11
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30000

Intervention / Treatment

Pediatric eCART

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections

Study ID: NCT06387667
Start Date: 2025-12-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Complete blood count

C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT)

CT chest

Microscopic examination

culture and sensitivity

Sponsor

New Valley University

Source: clinicaltrials.gov

Share:
Add to list